1. Soil DNA libraries for anticancer drug discovery

   • Robin K. Pettit

   Review 08 April 2004 Pages: 1 - 6

2. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer

   • Rama S. Ranga
   • Ramankutty Girija
   • Damodaran Chendil

   Original Article 24 March 2004 Pages: 7 - 15

   

3. A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth

   • Yasuji Ueda
   • Takehiro Yamagishi
   • Makoto Tanaka

   Original Article 03 April 2004 Pages: 16 - 24

   

4. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma

   • Rieko Katayama
   • Michael K. Huelsmeyer
   • David M. Vail

   Original Article 17 April 2004 Pages: 25 - 33

   

5. Fever as a risk factor causing delayed elimination of methotrexate in pediatric patients receiving high doses of cancer chemotherapy

   • Yoshiyuki Kagawa
   • Rika Mukohara
   • Michio Kojima

   Original Article 13 March 2004 Pages: 34 - 38

   

6. Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979)

   • Sophie Callies
   • Dinesh P. de Alwis
   • Leon Aarons

   Original Article 24 March 2004 Pages: 39 - 48

   

7. Inhibition of γ-glutamyl transpeptidase activity decreases intracellular cysteine levels in cervical carcinoma

   • P. Ruoso
   • D. W. Hedley

   Original Article 19 March 2004 Pages: 49 - 56

   

8. Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules

   • Michael A. Lea
   • Asif Shareef
   • Charles desBordes

   Original Article 19 March 2004 Pages: 57 - 63

   

9. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755

   • A. M. E. Bos
   • K. Boom
   • D. R. A. Uges

   Original Article 07 April 2004 Pages: 64 - 70

   

10. Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines

    • Dick Pluim
    • Robert C. A. M. van Waardenburg
    • Jan H. M. Schellens

    Original Article 19 March 2004 Pages: 71 - 78

    

11. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model

    • O. Glehen
    • O. A. Stuart
    • P. H. Sugarbaker

    Original Article 26 March 2004 Pages: 79 - 84

    

12. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates

    • Stacey L. Berg
    • Jeffery Stone
    • Susan M. Blaney

    Original Article 23 March 2004 Pages: 85 - 88

    

13. In vitro and in vivo effects of acetyldinaline on murine megakaryocytopoiesis

    • Donna A. Volpe
    • Patricia M. LoRusso
    • Ralph E. Parchment

    Original Article 11 March 2004 Pages: 89 - 94

    

14. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

    • Argun Akcakanat
    • Tatsuo Kanda
    • Katsuyoshi Hatakeyama

    Original Article 30 April 2004 Pages: 95 - 100